(Q40186710)

English

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

scientific article published on 13 October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 September 2017

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial (English)

1 reference

Europe PubMed Central

18 September 2017

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

Steven Rosenberg

17

object named as

Steven A Rosenberg

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Daniel W Lee

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

James N Kochenderfer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Maryalice Stetler-Stevenson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Yongzhi K Cui

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Cindy Delbrook

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Steven A Feldman

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Terry J Fry

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Rimas Orentas

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Marianna Sabatino

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Nirali N Shah

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Seth M Steinberg

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Dave Stroncek

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Nick Tschernia

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Constance Yuan

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Hua Zhang

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Ling Zhang

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Alan S Wayne

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Crystal L Mackall

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

0 references

publication date

13 October 2014

1 reference

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

385

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

9967

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

517-528

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Late effects of acute lymphoblastic leukemia therapy in patients diagnosed at 0-20 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of adults with acute lymphoblastic leukemia in Germany and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The myth of the second remission of acute leukemia in the adult

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Simplified process for the production of anti-CD19-CAR-engineered T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Revised response criteria for malignant lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

C-reactive protein: a critical update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Current concepts in the diagnosis and management of cytokine release syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Current management and challenges of malignant disease in the CNS in paediatric leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(14)61403-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25319501%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40186710&oldid=1903418481"